APA (7th ed.) Citation

K, K., A, P., S, A., D, Z., N, K., A, D., . . . T, G. (2025). Is the Addition of CO2 Laser to β3-Adrenoceptor Agonist Mirabegron Effective in the Management of Overactive Bladder? Results of a Randomized Controlled Trial. Medicina (Kaunas, Lithuania), 61(7), . https://doi.org/10.3390/medicina61071198

Chicago Style (17th ed.) Citation

K, Kypriotis, Prodromidou A, Athanasiou S, Zacharakis D, Kathopoulis N, Douligeris A, Athanasiou V, Michala L, and Grigoriadis T. "Is the Addition of CO2 Laser to β3-Adrenoceptor Agonist Mirabegron Effective in the Management of Overactive Bladder? Results of a Randomized Controlled Trial." Medicina (Kaunas, Lithuania) 61, no. 7 (2025). https://doi.org/10.3390/medicina61071198.

MLA (9th ed.) Citation

K, Kypriotis, et al. "Is the Addition of CO2 Laser to β3-Adrenoceptor Agonist Mirabegron Effective in the Management of Overactive Bladder? Results of a Randomized Controlled Trial." Medicina (Kaunas, Lithuania), vol. 61, no. 7, 2025, https://doi.org/10.3390/medicina61071198.